These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 12749244)

  • 1. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
    Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT
    Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of ribavirin plus interferon alpha on viraemia of GB virus-C/hepatitis G virus: comparison with interferon alpha alone.
    Kao JH; Lai MY; Chen W; Chen PJ; Chen DS
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1249-53. PubMed ID: 9918434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High initial dose combination regimen with interferon-alpha and ribavirin in chronic hepatitis C.
    Kotzev I; Ivanova I; Atanassova M; Atanassova A; Glinkova V; Gancheva D; Shalev I; Manevska B; Krasnaliev I; Tomcheva S
    Hepatogastroenterology; 2003; 50(50):463-6. PubMed ID: 12749248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha plus ribavirin combination therapy for the treatment of chronic hepatitis C in interferon non-responders.
    Hasan F; Asker H; al Shamali M; al Kalaoui M; al Nakib B
    Hepatogastroenterology; 2000; 47(36):1642-4. PubMed ID: 11149023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection.
    Sulkowski MS; Wasserman R; Brooks L; Ball L; Gish R
    J Viral Hepat; 2004 May; 11(3):243-50. PubMed ID: 15117326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus RNA load in relapsed patients: week two of treatment is the best time to predict the complete response.
    Halfon P; Khiri H; Tran A; Pénaranda G; Courcambeck J; Joly H; Ouzan D
    Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1067-71. PubMed ID: 14501613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
    Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA
    Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of chronic hepatitis C treatment in hemophilic patients.
    Husa P; Roznovsky L; Smejkal P; Husova L; Penka M; Dite P
    Hepatogastroenterology; 2005; 52(65):1541-4. PubMed ID: 16201114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis C.
    McHutchison JG; Shiffman ML; Cheung RC; Gordon SC; Wright TL; Pottage JC; McNair L; Ette E; Moseley S; Alam J
    Antivir Ther; 2005; 10(5):635-43. PubMed ID: 16152757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders.
    Brillanti S; Foli M; Di Tomaso M; Gramantieri L; Masci C; Bolondi L
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):130-4. PubMed ID: 10363198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of hepatitis C: alpha interferon and ribavirin.
    Reichard O; Schvarcz R; Weiland O
    Hepatology; 1997 Sep; 26(3 Suppl 1):108S-111S. PubMed ID: 9305674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Vega Palomares R; Planas Vilà R; Durández Lazaro R; Fábregas Puigtió S
    Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: sustained response in two patients with transfusion dependent thalassaemia.
    Hamidah A; Yong JF; Zulkifli HI; Jamal R
    Med J Malaysia; 2002 Sep; 57(3):353-6. PubMed ID: 12440276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon alpha plus ketoprofen or interferon alpha plus ribavirin in chronic hepatitis C non-responder to interferon alpha alone: results of a pilot study.
    Andreone P; Cursaro C; Gramenzi A; Fiorino S; Di Giammarino L; Miniero R; D'Errico A; Grigioni WF; Gasbarrini G; Bernardi M
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):688-94. PubMed ID: 10730561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon and ribavirin combination therapy: indications and schedules.
    Weiland O
    Forum (Genova); 2000; 10(1):22-8. PubMed ID: 10717255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily interferon therapy for chronic hepatitis C: a report of a community practice experience.
    Srinivas D; Mani H; Crumpler C; Van Thiel DH
    Hepatogastroenterology; 2002; 49(46):1053-7. PubMed ID: 12143200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study: longer duration of posttransplant hepatitis C virus therapy may increase the sustained response rate.
    Karasu Z; Akay S; Yilmaz F; Akarca U; Ersoz G; Gunsar F; Kilic M
    Transplant Proc; 2009 Nov; 41(9):3806-9. PubMed ID: 19917392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.